{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:05Z","timestamp":1790808185980,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.humimm.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:45:18Z","timestamp":1621385118000},"page":"634-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte\/macrophage surface markers: Relation to the degree of skin involvement"],"prefix":"10.1016","volume":"82","author":[{"given":"Mona Embarek","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"El-Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Thabet","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Sayed M.","family":"Abozaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Abdelmoez A. Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"A. Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"H El-Hakeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"S Makarem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdellatif Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2021.03.009_b0005","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2021.03.009_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","article-title":"Macrophage involvement in systemic sclerosis: do we need more evidence?","volume":"18","author":"Stifano","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.humimm.2021.03.009_b0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00296-018-4120-3","article-title":"M2 macrophages and their role in rheumatic diseases","volume":"39","author":"Bhattacharya","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.humimm.2021.03.009_b0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.humimm.2021.03.009_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12931-018-0777-0","article-title":"Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state","volume":"19","author":"Mitsi","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.humimm.2021.03.009_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Association","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2021.03.009_b0035","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.humimm.2021.03.009_b0040","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2021.03.009_b0045","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2021.03.009_b0050","first-page":"81","article-title":"Relationship between cutaneous and pulmonary involvement in systemic sclerosis","volume":"24","author":"Morelli","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2021.03.009_b0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.03.009_b0060","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2021.03.009_b0065","doi-asserted-by":"crossref","first-page":"i52","DOI":"10.1136\/ard.2009.117119","article-title":"What are the new milestones in the pathogenesis of systemic sclerosis?","volume":"69","author":"Hunzelmann","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2021.03.009_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-017-0417-1","article-title":"A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis","volume":"9","author":"Taroni","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.humimm.2021.03.009_b0075","first-page":"930","article-title":"Changes in circulating monocytes in patients with progressive systemic sclerosis","volume":"14","author":"Andrews","year":"1987","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2021.03.009_b0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.humimm.2021.03.009_b0085","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis\u2013associated pulmonary arterial hypertension","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2021.03.009_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2021.03.009_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-016-1214-8","article-title":"Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease","volume":"19","author":"Enomoto","year":"2017","journal-title":"Arthritis Res. Ther."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:54:54Z","timestamp":1759319694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0198885921000793"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.03.009","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte\/macrophage surface markers: Relation to the degree of skin involvement","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}